Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammationChi Kin Wong, Daniel J. Drucker, Rola Hammoud et al.|Cell Metabolism|2023Cited by 251
The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 miceLeticia Forny Germano, Daniel J. Drucker, Jacqueline A. Koehler et al.|Molecular Metabolism|2024Cited by 37